SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon has informed that the 48th Annual General Meeting (‘AGM’) of the Company will be held on Thursday August 06, 2026 at 3:30 P.M. (IST) through Video Conferencing (‘VC’) / Other Audio Visual Means (‘OAVM’) in compliance with applicable provisions of the Companies Act, 2013 (‘the Act’) and rules made thereunder, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) read with all applicable circulars on the matter issued by the Ministry of Corporate Affairs (‘MCA’) and the Securities and Exchange Board of India (‘SEBI’). Pursuant to the provisions of Regulation 30 and 34 of the SEBI Listing Regulations, please find enclosed the Notice of 48th AGM and Integrated Annual Report (BRSR, GRI & ESG Data Book FY 26 is a supplement to the Integrated Annual Report) of the Company for the Financial Year 2025-26. The same are also made available on the website of the Company at www.biocon.com. In compliance with the applicable Circulars issued by MCA and SEBI Listing Regulations, the Notice of the 48th AGM along with the Integrated Annual Report for the Financial Year 2025-26 are being sent only through electronic mode to those Members whose e-mail IDs are registered with the Registrar and Share Transfer Agents (‘RTA’) (in case of shares held in physical form) or with Depository Participants (‘DPs’) (in case of shares held in demat form). Further, pursuant to Regulation 36(1)(b) of SEBI Listing Regulations, the Company has also sent letter containing the weblink along with the path and QR Code to access the Notice of the 48th AGM and Integrated Annual Report of the Company for Financial Year 2025-2026, to those Members who have not registered their e-mail IDs with the RTA or with the DPs. Copy of the said letter is enclosed.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

434.65 -2.65 (-0.61%)
15-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1952.45
Dr. Reddys Labs. 1229.80
Cipla 1437.95
Zydus Lifesciences 1154.40
Lupin 2491.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: